Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial

OBJECTIVE: To confirm the rapid onset anti-suicidal benefits of ketamine in the short term and at six weeks, overall and according to diagnostic group. DESIGN: Prospective, double blind, superiority, randomised placebo controlled trial. SETTING: Seven French teaching hospitals between 13 April 2015...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbar, Mocrane, Demattei, Christophe, El-Hage, Wissam, Llorca, Pierre-Michel, Samalin, Ludovic, Demaricourt, Pierre, Gaillard, Raphael, Courtet, Philippe, Vaiva, Guillaume, Gorwood, Philip, Fabbro, Pascale, Jollant, Fabrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808464/
https://www.ncbi.nlm.nih.gov/pubmed/35110300
http://dx.doi.org/10.1136/bmj-2021-067194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808464/
https://www.ncbi.nlm.nih.gov/pubmed/35110300
http://dx.doi.org/10.1136/bmj-2021-067194

Ejemplares similares